Global Immunoprecipitation Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Immunoprecipitation Market was valued at $850 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.5% CAGR, to an estimated market size of $1.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The Immunoprecipitation market encompasses the tools, reagents, and techniques used to isolate and purify specific antigens or protein complexes from biological samples using antibody-antigen interactions. The scope includes kits, magnetic beads, and specialized buffers used in techniques such as Individual IP, Co-Immunoprecipitation (Co-IP), and Chromatin Immunoprecipitation (ChIP) for proteomics, drug discovery, and clinical research.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Immunoprecipitation Market in the period 2025-30:
- A significant shift from traditional agarose beads to magnetic bead-based systems is enhancing reproducibility and enabling automation in high-throughput labs.
- The rising demand for personalized medicine and targeted therapies is driving the use of IP for validating complex protein-protein interactions.
- Integration of IP with Mass Spectrometry (IP-MS) and Next-Generation Sequencing (ChIP-Seq) is expanding the market for high-sensitivity biomarker discovery.
- Increased government and private funding for proteomics and epigenomics research is fueling the adoption of specialized IP kits in academic institutes.
- The Asia-Pacific region is emerging as the fastest-growing market due to expanding biotechnology infrastructure and rising R&D investments in China and India.
- Market players are increasingly focusing on workflow standardization to reduce technical variability and non-specific binding in clinical research.
- The growing burden of chronic diseases and cancer is accelerating the demand for IP-based tools in drug discovery and therapeutic target validation.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Individual Protein IP
- Co-Immunoprecipitation (Co-IP)
- Chromatin Immunoprecipitation (ChIP)
- Others (RIP, Tagged Proteins)